BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Patent News
Synthetic Biologics, Inc. (SYN) Announces Allowance Of Key U.S. Composition Of Matter Patent For C. Difficile Program 10/22/2014
NeuroSigma, Inc. Receives Notice of Allowance Of U.S. Patent Application 10/21/2014
ERYtech Pharma Announces Granting Of New Patent In The United States 10/21/2014
Reflect Scientific, Inc. Continues To Solidify Patent Position In Cryogenic Technologies 10/21/2014
MiMedx Provides Update On Outstanding Patent Litigation 10/21/2014
Lpath, Inc. (LPTN) Granted Key European Patent Related To iSONEP And ASONEP Programs 10/20/2014
Amgen (AMGN) Files Lawsuit Against Sanofi (SAN.PA) And Regeneron (REGN) For Patent Infringement 10/17/2014
Noven Pharmaceuticals Inc. Files Patent Infringement Lawsuit Against Actavis (ACT) 10/17/2014
AcelRx Pharmaceuticals (ACRX) Provides Update On Its Patent Portfolio For Zalviso™ And Its Proprietary Platform Technologies 10/16/2014
Largest Biotech IPO Yet Could Be Derailed By Forward Pharma (FWP), Biogen Idec (BIIB) Patent Fight 10/15/2014
Mariel Therapeutics Announces Issuance Of Two Key U.S. Patents For The Use Of Bone Morphogenetic Protein -7 (BMP-7) In Osteoarthritis (OA) And Chronic Kidney Disease (CKD) 10/15/2014
Orgenesis Receives Patent For Potential Cure For Type 1 Diabetes 10/15/2014
BioAtla Receives Broad Patent For Antibody Development 10/14/2014
Prima Biomed (PRR.AX) Announces Immutep S.A.'s IMP321 Patent Application Receives Australian Notice Of Allowance 10/14/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Improvement Patent For Neuvax® (nelipepimut-S) In Japan 10/14/2014
Mission Pharmacal Company Settles Patent Infringement Suit With Virtus Pharmaceuticals 10/14/2014
Apricus Biosciences (APRI) Announces Notice Of Allowance Of U.S. Patent Application For Rayva™ 10/13/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Settlement Agreement That Resolves Patent Litigation In U.S. Related To AMITIZA 10/10/2014
R-Tech Ueno: Settlement Agreement That Resolves Patent Litigation In U.S. Related To AMITIZA® And Company Receives Additional Paragraph IV Notice 10/10/2014
BTG plc (BTG.L) Reaches Settlement Regarding CroFab® Patent Litigation 10/10/2014
Roche (RHHBY) Acquires Rights To Technology And Patent Applications From Abvitro To Support Next-Generation Sequencing Pipeline 10/9/2014
Vical Incorporated (VICL) Granted Six U.S. Patents For HSV-2 Vaccines 10/8/2014
Galena Biopharma  (GALE) Announces Notice Of Allowance Of U.S. Patent Application For Neuvax™ (Nelipepimut-S) Combination 10/8/2014
Aphios Granted United States Patent For Nanotechnology Formulation Of Poorly Soluble Drugs 10/8/2014
Neos Therapeutics Announces Issuance Of Key Patent Covering Its Extended Release Oral Disintegrating Tablet (XR-ODT) Platform Technology 10/8/2014
Aciex Therapeutics Announces Issuance Of Separate U.S. Patents Covering Two Leading Product Candidates 10/8/2014
MediGene AG (MDGEF.PK) Receives Patent For TCR-Modified T Cell Immunotherapy In Australia 10/8/2014
Bristol-Myers Squibb Company (BMY) Statement On Sustiva (Efavirenz) In The U.S. 10/8/2014
Pivotal Therapeutics Inc. Receives Notification Of Allowance For U.S. Patent Related To Combination VASCAZEN® And Cholesterol Absorption Inhibitor 10/8/2014
Histogen, Inc.’s Composition For Oncology Treatments Receives US Patent 10/8/2014
Pluristem Therapeutics (PSTI) Wins Cell Therapy Patent Case In Europe; European Patent Office Confirms Validity Of Amended Claims 10/7/2014
Eleven Biotherapeutics (EBIO) Granted U.S. Composition-of-Matter Patent For EBI-005 10/7/2014
Pivotal Therapeutics Inc. Announces Notification Of Patent Allowance For U.S. Application 13/584,480 Related To Combination Product Of VASCAZEN® And Statin Therapy 10/7/2014
Halozyme Therapeutics, Inc. (HALO) Announces Issuance Of U.S. Patent For Companion Diagnostic For PEGPH20 10/7/2014
Enzo Biochem (ENZ) Awarded Patent For Novel Vectors Involving Gene Therapy Treatments For Cancer, Virus Infections And Genetic Diseases 10/7/2014
Aegis Therapeutics, LLC Awarded 2nd Patent For Monoclonal Antibody Formulations That Avoid Oxidative Damage Due To Polysorbate Surfactants 10/7/2014
Boston Therapeutics, Inc. Files Patent Application For Novel Therapeutic Uses Of BTI-320 10/7/2014
IRIDEX Corporation (IRIX) Granted U.S. Patent For Disposable MicroPulse® Delivery Device For The Non-Invasive Treatment Of Glaucoma 10/7/2014
CleveXel Pharma To License Two New Oncology Patents From SATT Sud Est 10/6/2014
U.S. Patent Office Institutes Inter Partes Review Brought By MonoSolRx LLC Against All Claims In Key BDSI BEMA Patent 10/6/2014
Horizon Pharma plc.  (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of Additional Notice Of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets 10/2/2014
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Ferric Citrate Covering Orally Administrable Forms 10/1/2014
Stemedica Cell Technologies, Inc. Secures U.S. Patent To Use Multiple Stem Cell Lines Simultaneously To Treat Ischemic Stroke 10/1/2014
TherapeuticsMD, Inc.  (TXMD) Granted Two New Patents 10/1/2014
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Canadian Patent For Inhibition Or Reversal Of Skin Aging 9/30/2014
Edge Therapeutics, Evonik Industries Granted EG-1962 Composition Of Matter Patent 9/30/2014
KemPharm, Inc. Receives Patent From The USPTO For Novel Prodrug Of Hydromorphone, KP511 9/30/2014
U.S. Patent and Trademark Office Issues Can-Fite BioPharma (CFBI) Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/30/2014
Opexa Pharmaceuticals, Inc. Strengthens Patent Portfolio With Expansion Into B-Cell Diseases And Announces Allowance Of 98th T-Cell Patent 9/29/2014
Actavis (ACT) Confirms Generic Butrans® Patent Challenge 9/26/2014
Regulus Therapeutics, Inc. Announces Notice Of Allowance From U.S. Patent Office Related To Microrna-103/107 Program In Metabolic Disorders 9/24/2014
iCeutica Inc. Receives Key Patent For Solumatrix Fine Particle Technology™ Platform 9/23/2014
Telormedix Granted European Patent For Vesimune 9/22/2014
Spherix (SPEX) Notified By United States Patent & Trademark Office Of New Standard Essential Patent Issued To Spherix 9/22/2014
Kymab Succeeds In Revoking Regeneron Pharmaceuticals, Inc. (REGN)’s European Patent 9/19/2014
Salix Pharmaceuticals, Ltd. (SLXP) Secures Additional Intellectual Property Relating To Rifaximin 9/18/2014
Biostar Pharmaceuticals, Inc. (BSPM) Files A PRC Patent Application For Oleanolic Acid Injection, Its New Drug Product For Hepatitis B And Liver Cancer 9/18/2014
Biocept, Inc. (BIOC) Granted Patent In China For Its Microfluidic Channel Technology Used To Capture Circulating Tumor Cells 9/18/2014
Patent Position Of Merus' MeMo® Mouse Strengthened by Ruling of European Patent Office 9/18/2014
Regen BioPharma Files Patent Application On New Therapy That Uses the "Innate" Immune System To Kill Cancer 9/17/2014
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Issue Of A New Patent For Beleodaq™ (Belinostat) For Injection With Patent Term Adjustment Till 2027 9/16/2014
Trevena, Inc. (TRVN) Granted Key U.S. Composition Of Matter Patent For TRV130 9/16/2014
Advanced Medical Isotopes Corporation Licensed Brachytherapy Seed Patent Granted 9/16/2014
Oculus Innovative Sciences, Inc. (OCLS) Strengthens Intellectual Property Portfolio With Allowance Of Four New Patents For Microcyn® Technology 9/16/2014
Galectin Therapeutics Announces Issuance Of U.S. Patent For GR-MD-02 In Diabetic Nephropathy 9/15/2014
Dyax Corp. (DYAX) Announces Issuance Of Two Key U.S. Patents For DX-2930 9/15/2014
Marina Biotech, Inc. (MRNA) Announces The Continued Worldwide Expansion Of Its Delivery Technology Intellectual Property Estate 9/15/2014
NeoStem, Inc. Announces Licensing Of Patent Portfolio From The Rockefeller University Expanding Its Cancer Immunotherapy Intellectual Property Portfolio 9/11/2014
Marrone Bio Innovations Receives Patent For Use Of Chromobacterium To Control Corn Rootworm Larvae Infestation 9/11/2014
Lakewood-Amedex Inc. Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 9/11/2014
Egalet Announces Issuance Of U.S. Patents Covering Guardian™ Technology And Product Candidates 9/11/2014
Gentag, Inc.'s Disposable NFC Biomarker Patent Receives Notice Of Allowance From The European Patent Office 9/9/2014
GenSpera Receives Patent On Prodrug Targeted For Prostate Cancer 9/9/2014
Mersana Therapeutics, Inc. Strengthens Antibody-Drug Conjugate Intellectual Property Position With Issuance Of Three Additional U.S. Patents 9/9/2014
Flexion Therapeutics (FLXN) Announces Issuance Of U.S. Composition Of Matter Patent For Lead Candidate FX006 9/9/2014
BerGenBio AS Granted Platform Patent - Cellselect™ Platform Also Described In Peer-Reviewed Journal 9/8/2014
Argos Therapeutics, Inc. (ARGS) Announces Issuance Of Arcelis® Technology Platform Patent 9/8/2014
Advanced Cell Technology Announces Issuance Of Patent Covering Dendritic Cells Manufacturing From Renewable Stem Cell Sources 9/5/2014
Can-Fite BioPharma (CFBI) Issued Japanese Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/5/2014
Alitair Pharmaceuticals Receives A U.S. Composition Of Matter Patent For Benzonatate Polacrilex 9/5/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance of Fourth US Patent Protecting Oxtellar XR® 9/4/2014
KineMed, Inc. Receives U.S. Patent Allowance For Noscapine To Treat ALS, Parkinson’s Disease, And Diabetic Neuropathy 9/4/2014
Clearside Biomedical Announces Fourth Patent Allowance In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 9/4/2014
Rexahn Pharmaceuticals, Inc. (RNN) Receives A Notice Of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted Cancer Drug Delivery Platform 9/3/2014
Suven Life Sciences Ltd Secures (3) Product Patents For Their NCEs In South Korea, China And Canada 9/3/2014
Orexigen Therapeutics, Inc. (OREX) Expands NB32 Intellectual Property Portfolio With New U.S. Patent 9/3/2014
DelMar Pharmaceuticals Receives Notice Of Allowance For Second U.S. Patent For VAL-083 9/3/2014
United States Patent & Trademark Office Issues Three New Standard Essential Patents To Spherix (SPEX) 9/2/2014
Cellular Dynamics International Awarded U.S. Patent Covering Automated Production Of All Human Pluripotent Stem Cells 8/29/2014
United Therapeutics Corporation (UTHR) Release: District Court Decision Received In Remodulin Patent Case 8/29/2014
iBio, Inc. (IBIO) Receives European Patent Allowances For Protein Expression Technology 8/28/2014
Onxeo Strengthens Beleodaq® Patent Protection In The U.S. Until 2027 8/28/2014
TxCell Granted Five New Patents In Major Global Territories For Core Technology And Astria Platform Since January 2014 8/27/2014
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 8/27/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Rnai-Mediating, Double-Stranded Molecules Of 19 To 52 Nucleotides In Length 8/27/2014
Ryogen LLC Awarded Two U.S. Patents Directed To Hepatitis C And Diabetes 8/27/2014
Actavis (ACT) Confirms Generic Neupro® Patent Challenge 8/25/2014
MultiCell Technologies Inc. (MCET.OB) Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer 8/25/2014
Dicerna Pharmaceuticals (DRNA) Announces The Issuance Of Multiple Patents Covering Claims For Dicer Substrate SiRNAs 8/21/2014
BioLineRx Ltd. Receives Notice Of Allowance For U.S. Patent On BL-7010 Covering Use Of Novel Polymer In Prevention Of Gluten Toxicity 8/21/2014
Achillion Pharmaceuticals, Inc. (ACHN) Granted U.S. Patent For ACH-3102 And Structurally Related NS5A Inhibitors 8/20/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Rnai-Mediating Double-Stranded Molecules Comprising Up To 25 Base Pairs 8/20/2014
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent in Spain For Oral Administration Of Insulin 8/19/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Further Expanding Stem Cell Technology Platform 8/19/2014
BioBlast Pharma (ORPN) Receives Notice Of Allowance From USPTO For Its Novel Fusion Protein-Based Platform For The Treatment Of Friedrich's Ataxia 8/18/2014
Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent For Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform 8/14/2014
Access Pharmaceuticals (ACCP) Awarded Japan Patent For MuGard And ProctiGard 8/14/2014
La Jolla Pharmaceutical Company (LJPC) Receives Notice Of Allowance For Additional Patent Claims Covering Modified Pectin For The Treatment Of Chronic Inflammation 8/14/2014
Trevi Therapeutics Announces The Issuance Of Two Patents Covering The Oral Sustained Release Formulation Of Nalbuphine ER 8/14/2014
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Nonalcoholic Fatty Liver Disease 8/12/2014
eAgile Awarded Patent For RFID Intelligent Packaging Breakthrough 8/12/2014
EnGeneIC Pty Ltd Receives Patent From The USPTO For EDV™ Nanocell Technology 8/11/2014
InVivo Therapeutics Corporation (NVIV) Receives Notice Of Allowance On Patent Covering Neuro-Spinal Scaffold And Neuro-Spinal Scaffold Plus Stem Cells 8/11/2014
Extending Patent Protections To Discover The Next Life-Saving Drugs 8/11/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their Nces In Australia And Eurasia 8/6/2014
Islet Sciences Receives Notice Of Allowance For U.S. Patent Covering Novel IL-12 Inhibitors 8/6/2014
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of Additional Notices Of Allowance With Claims Covering VIMOVO®(Naproxen / Esomeprazole) Delayed Release Tablets 8/6/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 8/6/2014
Menlo Park's TesoRx Locks In $10 Million, Secures Key Patent And Taps Renowned Urologist As Chief Medical Officer 8/5/2014
Galectin Therapeutics Receives U.S. Patent For GR-MD-02 Composition Of Matter 8/5/2014
Trevena, Inc. (TRVN) Granted Key U.S. Method Of Use Patent For TRV027 8/5/2014
United States Patent Issued To Adamas Pharmaceuticals (ADMS) 8/5/2014
CDEX Inc. (CDEX) Granted Notice Of Allowance For U.S. Patent Application Covering Identification And Determination Of Chemical Substances Using Enhanced Photoemission Spectroscopy 7/31/2014
Mystic Pharmaceuticals Receives Notice Of Allowance For Novel Powder Drug Delivery Technology 7/31/2014
Transgenomic, Inc. (TBIO) Announces Issuance Of New European Patent Covering COLD-PCR Technologies 7/31/2014
GenSpera Announces US Patent For Methods And Compositions For The Detection, Imaging And Treatment Of Cancer 7/30/2014
Ryogen LLC Awarded Two Patents Directed To Polynucleotide Sequences That Play Key Roles In Various Cancers 7/29/2014
Advaxis, Inc. Receives Notice Of Allowance For Cancer Immunotherapies Patent In Japan 7/28/2014
VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds For Prevention Of Mosquito-Borne Illnesses 7/28/2014
MYOS (MYOS) Receives Notice Of Allowance Of U.S. Patent Application For Proprietary Manufacturing Methods Of Fortetropin 7/24/2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE 7/22/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Conjugate-Based Delivery Of RNA Therapeutics 7/22/2014
U.S. Patent Office Grants McCord Research Endothelial Cell Treatment Patent 7/22/2014
Particle Sciences And Eyeon Therapeutics Receive Patent On Novel Dry Eye Technology 7/22/2014
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers 7/21/2014
Agile Therapeutics, Inc. Announces Allowance Of Additional Patent Claims For Skinfusion® 7/18/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Integral Molecular, Inc. Announces Patent Allowance For Dengue Research Technology 7/18/2014
Columbia Laboratories, Inc. (CBRX) Expands Its Intellectual Property Portfolio Following Receipt Of U.S. Patent 7/17/2014
Lipocine Inc. (LPCN) Announces Issuance Of U.S. Patent For LPCN 1021 7/16/2014
InSite Vision (ISV) Announces The Issuance Of Broad U.S. Patent Covering Bromfenac Formulations In Durasite® 7/16/2014
Arena Pharmaceuticals, Inc. (ARNA) Issued Patent For APD371 By United States Patent And Trademark Office 7/16/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
Kraig Biocraft Laboratories, Inc. Announces U.S. Patent And Trademark Office Has Registered The Company's Monster Silk® Trademark 7/15/2014
C4X Discovery Patent Granted In Japan 7/15/2014
BioTime (BTX) Announces Issuance Of 14 Patents In The Fields Of Regenerative Medicine, And Cancer Diagnosis And Therapy 7/14/2014
Transplant Genomics Inc. Announces Exclusive License To Patent Rights Co-Owned By The Scripps Research Institute And Northwestern University 7/14/2014
Zogenix, Inc. (ZGNX) Announces New Patent Valid Through 2032 For DosePro® Needle-Free Delivery System 7/14/2014
Actavis (ACT) Confirms Generic Diclegis® Patent Challenge 7/14/2014
Cellular Dynamics International Awarded Patents Covering Derivation Of Pluripotent Stem Cells From Fresh Or Banked Human Blood Samples 7/10/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014
Rosetta Genomics Ltd. (ROSG) Receives Notice Of Allowance For U.S. Patent For The Treatment Of Ovarian Cancer 7/10/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Palatin Technologies (PTN) Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides 7/9/2014
Alkermes plc (ALKS) Announces Notices of Allowance For U.S. Patents For Four CNS Pipeline Candidates 7/9/2014
ZS Pharma (ZSPH) Announces Allowance Of Two U.S. Patent Applications For ZS-9 7/8/2014
Sirnaomics Strengthens Its IP Position For Advancing The Company's Novel siRNA Therapeutics Programs 7/8/2014
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014
Aegis Therapeutics, LLC Awarded US Patent For Stable "Shirt-Pocket" Insulin Suitable For Metered Nasal Spray Or Injection 7/8/2014
Actavis (ACT) Confirms Generic Ampyra® Patent Challenge 7/8/2014
Seres Health Announces Allowance For Key Patent On The Use Of Synergistic Bacterial Compositions 7/7/2014
Q Therapeutics, Inc. Announces First U.S. Patent Relating To Fifth Patent Family On Neural Cells 7/7/2014
22nd Century Group, Inc. Announces Allowance of U.S. Patent For Regulating Nicotine in Tobacco Using Transcription Factor Gene 7/3/2014
OncoMed Pharmaceuticals, Inc. (OMED) Granted Broad FZD-Fc Composition-Of-Matter And Use Patent In U.S. 7/2/2014
Collegium Pharmaceutical, Inc. Announces Issuance Of U.S. Patent Covering Oxycodone DETERx®, An Abuse-Deterrent, Extended-Release Opioid Product 7/2/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Broad U.S. Patent For Neuvax™ (Nelipepimut-S) 7/1/2014
Valensa Is Granted New Patents For "Worry Free" Chia-Based Ingredients 7/1/2014
Mati Therapeutics Expands Patent Portfolio 6/30/2014
Actavis (ACT) Confirms Generic Zubsolv® Patent Challenge 6/30/2014
Premier Biomedical Announces Important Patent Award For A Potential Multi-Billion Dollar Drug For The Treatment Of Fibromyalgia And Neuralgia 6/30/2014
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014
Opko Health, Inc. Granted Patent from European Patent Office For Lagova™ 6/27/2014
Regulus Therapeutics, Inc. Announces Patent Grant From U.S. Patent Office In Sarnow Patent Estate On Microrna Therapeutics For The Treatment Of HCV 6/25/2014
Shire Pharmaceuticals (SHPG) Release: Vyvanse® Patents Found To Be Infringed And Valid By U.S. District Court 6/25/2014
Ryogen LLC Is Awarded Patent For Polynucleotides Related To Tumor-Suppressing Subtransferable Candidate 4 6/24/2014
BioInvent (BOVNF) Granted U.S. Patent For BI-505 And Apoptosis-Inducing ICAM-1 Antibodies 6/24/2014
Advaxis, Inc. Receives Notice Of Allowance From U.S. Patent Office For Two Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy ADXS-Cher2 6/23/2014
Perrigo Company (PRGO) Announces Settlement In Proair® HFA Patent Case 6/20/2014
Actavis (ACT) Confirms District Court Ruling In Generic Exelon® Patch Patent Suit 6/19/2014
Pluristem Therapeutics (PSTI) Granted Patent In Russia For Treatment Of Inflammatory Bowel Disease Using Placenta-Derived Cells 6/19/2014
TriLink BioTechnologies Awarded Patents For Novel Ligation Technology In US, Europe And New Zealand 6/19/2014
Drawbridge Pharmaceuticals Granted New Anaesthesia Patent For Phaxan™ In China 6/18/2014
Keryx Biopharmaceuticals (KERX) Announces Issuance Of Two U.S. Patents For Zerenex(TM) Covering Orally Administrable Forms Of Ferric Citrate 6/18/2014
ProLynx Issues U.S. Patent Covering Controlled Release Drug Conjugates 6/18/2014
Patrys Limited (PAB.AX) Granted Third U.S. Patent For Lead Clinical Product PAT-SM6 6/18/2014
Forest Laboratories, Inc. (FRX) Obtains Six Months U.S. Pediatric Exclusivity for NAMENDA® and NAMENDA XR® 6/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Reaches Settlements In NUVIGIL® Patent Case 6/17/2014
ArmaGen Technologies, Inc. Receives Notice Of Allowance For U.S. Patent Covering Novel Investigational Therapy For Hunter Syndrome 6/17/2014
Essentialis Announces The Grant Of Its First Japanese Patent Which Provides Extensive Protection To DCCR In The Treatment Of Prader-Willi Syndrome 6/17/2014
Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions 6/16/2014
Arrowhead Research Corporation (ARWR) Issues A Statement On Intellectual Property Protection For ARC-520 6/16/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Expanding Stem Cell Technology Platform 6/16/2014
Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents 6/12/2014
Alnylam Pharmaceuticals (ALNY) Announces United States Patent And Trademark Office (USPTO) Issues Patent Covering Rnai Therapeutics For The Treatment Of Hepatitis B Virus (HBV) Infection 6/12/2014
Zealand Pharma  (ZEAL.CO)’s GLP-2 Analogue European Patent Rights Upheld By The European Patent Office Opposition Division 6/12/2014
Spherix (SPEX) Commences Litigation Against Verizon For Patent Infringement 6/12/2014
The United States Patent Office Grants Neol Biosolutions The Patent For The Technology Microbioil-1® 6/12/2014
Catabasis Pharmaceuticals, Inc. Announces Issuance Of Three New US Patents For CAT-1000 Series 6/11/2014